Anti-Cancer Activity, DFT and molecular docking study of new BisThiazolidine amide

In this study, a series of bis amide thiazolidine derivatives (Q1-Q6) were synthesized and their anticancer activity was evaluated against prostate (PC3) and breast (MCF7) cancer cells and normal cells line activity was evaluated against breast (MCF10), prostate (PNT1A) and living human cells (HUVEC) cancer cells. The thiazolidine rings were built from penicillamine and aromatic aldehydes (A1-A6), then converted to acetyl thiazolidines (B1-B6) using acetic anhydride, and finally linked with phenylenediamine to form the final compounds (Q1-Q6). By spectroscopic method, the researchers identified the synthesized compounds and found them to be more selective towards PC3 cells. Notably, compounds Q1 and Q3 displayed the highest activity against PC3. Docking simulations were performed for Q1, Q4, and Q5 against protein structures related to cancer (2FVD and 1SJ0). Additionally, DFT calculations were used to determine various molecular properties providing insights into the compounds’ stability and reactivity. This study identified promising bis (thiazolidine-2- carboxamide) derivatives with selective activity against prostate cancer. In this study, a series of bis amide thiazolidine derivatives (Q1-Q6) were synthesized and their anticancer activity was evaluated against prostate (PC3) and breast (MCF7) cancer cells and normal cells line activity was evaluated against breast (MCF10), prostate (PNT1A) and living human cells (HUVEC) cancer cells. The thiazolidine rings were built from penicillamine and aromatic aldehydes (A1-A6), then converted to acetyl thiazolidines (B1-B6) using acetic anhydride, and finally linked with phenylene diamine to form the final compounds (Q1-Q6). Notably, compounds Q1 and Q3 displayed the highest activity against PC3, with IC50 values of 81 and 89 µg/ml, respectively. Docking simulations were performed for Q1, Q4, and Q5 against protein structures related to cancer (2FVD and 1SJ0). Additionally, DFT calculations were used to determine various molecular properties like HOMO/LUMO energies, band gap, and other descriptors, providing insights into the compounds’ stability and reactivity.

Authors

Institutions

Publication Details

Journal
Results in Chemistry
Published
2024-10-16
DOI
https://doi.org/10.1016/j.rechem.2024.101835
Citations
8
Primary Topic
Synthesis and biological activity
Type
article
Field-Weighted Citation Impact
2.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-Cancer Activity, DFT and molecular docking study of new BisThiazolidine amide

Dawood S. Abid, Kawkab Ali Hussein, Mohammed Aufy, Ahmed A. Majed et al.
8 citations
Results in Chemistry
Synthesis and biological activity
2.00
article

Anti-Cancer Activity, DFT and molecular docking study of new BisThiazolidine amide

Dawood S. Abid, Kawkab Ali Hussein, Mohammed Aufy, Ahmed A. Majed, Mostafa A. Abdel-Maksoud, Mohamed H. Kotob, Ahmed Elwahsh, Haider A. Omran
article en
8 citations

Abstract

In this study, a series of bis amide thiazolidine derivatives (Q1-Q6) were synthesized and their anticancer activity was evaluated against prostate (PC3) and breast (MCF7) cancer cells and normal cells line activity was evaluated against breast (MCF10), prostate (PNT1A) and living human cells (HUVEC) cancer cells. The thiazolidine rings were built from penicillamine and aromatic aldehydes (A1-A6), then converted to acetyl thiazolidines (B1-B6) using acetic anhydride, and finally linked with phenylenediamine to form the final compounds (Q1-Q6). By spectroscopic method, the researchers identified the synthesized compounds and found them to be more selective towards PC3 cells. Notably, compounds Q1 and Q3 displayed the highest activity against PC3. Docking simulations were performed for Q1, Q4, and Q5 against protein structures related to cancer (2FVD and 1SJ0). Additionally, DFT calculations were used to determine various molecular properties providing insights into the compounds’ stability and reactivity. This study identified promising bis (thiazolidine-2- carboxamide) derivatives with selective activity against prostate cancer. In this study, a series of bis amide thiazolidine derivatives (Q1-Q6) were synthesized and their anticancer activity was evaluated against prostate (PC3) and breast (MCF7) cancer cells and normal cells line activity was evaluated against breast (MCF10), prostate (PNT1A) and living human cells (HUVEC) cancer cells. The thiazolidine rings were built from penicillamine and aromatic aldehydes (A1-A6), then converted to acetyl thiazolidines (B1-B6) using acetic anhydride, and finally linked with phenylene diamine to form the final compounds (Q1-Q6). Notably, compounds Q1 and Q3 displayed the highest activity against PC3, with IC50 values of 81 and 89 µg/ml, respectively. Docking simulations were performed for Q1, Q4, and Q5 against protein structures related to cancer (2FVD and 1SJ0). Additionally, DFT calculations were used to determine various molecular properties like HOMO/LUMO energies, band gap, and other descriptors, providing insights into the compounds’ stability and reactivity.

Results in ChemistryVol. 12
University of Basrah (IQ), University of Vienna (AT), King Saud University (SA), Kepler Universitätsklinikum (AT), University of Brescia (IT), Ministry of Higher Education and Scientific Research (AE), Assiut University (EG)
King Saud University
Good health and well-being
Openalex Percentile: Top 14%
Synthesis and biological activity
2.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.